Mayne Pharma is an ASX-listed specialty pharmaceutical company focused on commercializing pharmaceuticals. With a 40-year track record, Mayne Pharma develops innovative oral drug delivery systems and markets a robust portfolio of branded and generic medications across various therapeutic areas, including women's health and dermatology. The company operates globally, with capabilities in pharmaceutical development, analytical testing, and commercial manufacturing. Mayne Pharma is committed to sustainability, ethical sourcing, and enhancing patient access to life-improving medications and has a strong presence in the US and Australian markets.